Patents Assigned to ORYZONG GENOMICS, S.A.
  • LYSINE DEMETHYLASE INHIBITORS FOR THROMBOSIS AND CARDIOVASCULAR DISEASES
    Publication number: 20140296255
    Abstract: The invention relates to methods and compositions for the treatment or prevention of thrombosis, thrombus formation, a thrombotic event or complication, or a cardiovascular disease or event. In particular, the invention relates to an LSD inhibitor such as a 2-cyclylcyclopropan-1-amine derivative, a phenelzine derivative and a propargylamine derivative, for use in treating or preventing thrombosis, thrombus formation, a thrombotic event or complication, or a cardiovascular disease or event.
    Type: Application
    Filed: May 21, 2012
    Publication date: October 2, 2014
    Applicant: ORYZONG GENOMICS, S.A.
    Inventors: Tamara Maes, Marc Martinell Pedemonte